Literature DB >> 12916818

Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.

G L Gadbury1, C S Coffey, D B Allison.   

Abstract

This paper brings together some modern statistical methods to address the problem of missing data in obesity trials with repeated measurements. Such missing data occur when subjects miss one or more follow-up visits, or drop out early from an obesity trial. A common approach to dealing with missing data because of dropout is 'last observation carried forward' (LOCF). This method, although intuitively appealing, requires restrictive assumptions to produce valid statistical conclusions. We review the need for obesity trials, the assumptions that must be made regarding missing data in such trials, and some modern statistical methods for analysing data containing missing repeated measurements. These modern methods have fewer limitations and less restrictive assumptions than required for LOCF. Moreover, their recent introduction into current releases of statistical software and textbooks makes them more readily available to the applied data analyses.

Entities:  

Mesh:

Year:  2003        PMID: 12916818     DOI: 10.1046/j.1467-789x.2003.00109.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  50 in total

Review 1.  Pragmatic randomised controlled trials in parenting research: the issue of intention to treat.

Authors:  Karen Whittaker; Chris Sutton; Chris Burton
Journal:  J Epidemiol Community Health       Date:  2006-10       Impact factor: 3.710

2.  Does analysis using "last observation carried forward" introduce bias in dementia research?

Authors:  Frank J Molnar; Brian Hutton; Dean Fergusson
Journal:  CMAJ       Date:  2008-10-07       Impact factor: 8.262

Review 3.  Best (but oft-forgotten) practices: designing, analyzing, and reporting cluster randomized controlled trials.

Authors:  Andrew W Brown; Peng Li; Michelle M Bohan Brown; Kathryn A Kaiser; Scott W Keith; J Michael Oakes; David B Allison
Journal:  Am J Clin Nutr       Date:  2015-05-27       Impact factor: 7.045

4.  Effects of dietary composition on energy expenditure during weight-loss maintenance.

Authors:  Cara B Ebbeling; Janis F Swain; Henry A Feldman; William W Wong; David L Hachey; Erica Garcia-Lago; David S Ludwig
Journal:  JAMA       Date:  2012-06-27       Impact factor: 56.272

5.  Long-term adherence to the New Nordic Diet and the effects on body weight, anthropometry and blood pressure: a 12-month follow-up study.

Authors:  Sanne Kellebjerg Poulsen; Charlotte Crone; Arne Astrup; Thomas Meinert Larsen
Journal:  Eur J Nutr       Date:  2014-03-25       Impact factor: 5.614

6.  Validity of Clinical Body Weight Measures as Substitutes for Missing Data in a Randomized Trial.

Authors:  David Arterburn; Laura Ichikawa; Evette J Ludman; Belinda Operskalski; Jennifer A Linde; Emily Anderson; Paul Rohde; Robert W Jeffery; Greg E Simon
Journal:  Obes Res Clin Pract       Date:  2008-12       Impact factor: 2.288

7.  The effect of three different ad libitum diets for weight loss maintenance: a randomized 18-month trial.

Authors:  Anette Due; Thomas M Larsen; Huiling Mu; Kjeld Hermansen; Steen Stender; Søren Toubro; David B Allison; Arne Astrup
Journal:  Eur J Nutr       Date:  2015-12-12       Impact factor: 5.614

8.  The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials.

Authors:  Craig H Mallinckrodt; Joel Raskin; Madelaine M Wohlreich; John G Watkin; Michael J Detke
Journal:  BMC Psychiatry       Date:  2004-09-08       Impact factor: 3.630

9.  Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review.

Authors:  Frank J Molnar; Malcolm Man-Son-Hing; Brian Hutton; Dean A Fergusson
Journal:  Open Med       Date:  2009-03-24

10.  The impact of analytic method on interpretation of outcomes in longitudinal clinical trials.

Authors:  A Prakash; R C Risser; C H Mallinckrodt
Journal:  Int J Clin Pract       Date:  2008-06-28       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.